Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Memantine diminishes pain in diabetic neuropathy

Feb. 4, 2000

Berlex seeks FDA approval of long-acting intrauterine contraceptive

Feb. 4, 2000

IND filed for nasal leuprolide as endometriosis therapy

Feb. 3, 2000

NPS Allelix drug candidate enhances bone growth in space shuttle experiments

Feb. 3, 2000

Diacyl hydrazine compounds from SB target cathepsin K

Feb. 2, 2000

Diabetes vaccine from Diamyd completes phase I testing

Feb. 2, 2000

Ares-Serono licenses rhLIF from Amrad for infertility indication

Feb. 2, 2000

PEG-rHuMGDF tested as adjunct to chemotherapy in AML

Feb. 1, 2000

Novel compounds to treat thyroid disorders in development at Lotus

Feb. 1, 2000

Synthetic thyromimetics useful for hyperthyroidism, cardiac arrhythmias

Jan. 31, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 3, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...